C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina.
about
Gene expression patterns in peripheral blood correlate with the extent of coronary artery disease.C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study.Variation in high-sensitivity C-reactive protein levels over 24 hours in patients with stable coronary artery disease.A genetic variant rs1801274 in FCGR2A as a potential risk marker for Kawasaki disease: a case-control study and meta-analysis.Roles of the metabolic syndrome, HDL cholesterol, and coronary atherosclerosis in subclinical inflammation.Relative value of multiple plasma biomarkers as risk factors for coronary artery disease and death in an angiography cohort.A lack of association between the CRP rs2794520 polymorphism and coronary artery disease.C-Reactive Protein: How Has JUPITER Impacted Clinical Practice?Differential relationship between metabolic syndrome score and severity of coronary atherosclerosis as assessed by angiography in a non-diabetic and diabetic Korean population.The impact of diurnal fasting during Ramadan on the lipid profile, hs-CRP, and serum leptin in stable cardiac patientsBiomarkers of chronic inflammatory state in uremia and cardiovascular disease.Inflammatory markers: linking unstable plaques to coronary event, an interventional perspective.CRP is or is not a reliable marker of ischaemic heart disease?Total cholesterol content of erythrocyte membranes is associated with the severity of coronary artery disease and the therapeutic effect of rosuvastatinDoes C-reactive protein contribute to atherothrombosis via oxidant-mediated release of pro-thrombotic factors and activation of platelets?C-reactive protein as a prognostic tool in cardiovascular practices: should CRP testing be ordered along with lipid profiles?Assessment of serum leptin, pregnancy-associated plasma protein A and CRP levels as indicators of plaque vulnerability in patients with acute coronary syndrome.Early detection of C-reactive protein and von Willebrand factor levels in Malaysian patients with acute coronary syndrome.Comparative value of simple inflammatory markers in the prediction of left ventricular systolic dysfunction in postacute coronary syndrome patients.Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patientsThe Impact of Ischemic Time on the Predictive Value of High-Sensitivity C-Reactive Protein in ST-Segment Elevation Myocardial Infarction Patients Treated by Primary Percutaneous Coronary Intervention.Clinical and angiographic correlation of high-sensitivity C-reactive protein with acute ST elevation myocardial infarctionAssociation between Resting Heart Rate and Inflammatory Markers (White Blood Cell Count and High-Sensitivity C-Reactive Protein) in Healthy Korean People.Platelet hyperfunction as risk factor for chronic and acute coronary events.The Correlation between High-Sensitivity C-Reactive Protein (hsCRP) Serum Levels and Severity of Coronary Atherosclerosis.The incremental value of lipids and inflammatory biomarkers in determining residual cardiovascular risk.Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.Chronic inflammatory muscle diseases and risk of coronary artery disease.Inflammation and arrhythmias: potential mechanisms and clinical implications.Observational Prospective study to esTIMAte the rates of outcomes in patients undergoing PCI with drug-eluting stent implantation who take statins -follow-up (OPTIMA II).High-density lipoprotein cholesterol, C-reactive protein, and prevalence and severity of coronary artery disease in 5641 consecutive patients undergoing coronary angiography.Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris.Effect of Non-Surgical Periodontal Treatment on Clinical and Biochemical Risk Markers of Cardiovascular Disease: A Randomized Trial.Linking inflammation and thrombosis: Role of C-reactive proteinAnalysis of the association between IL-23R rs11209026 polymorphism and incidence of atherosclerosis.C-reactive protein in unstable angina: clinical and angiographic correlation.Expression of EMMPRIN (CD147) on circulating platelets in vivo.Contemporary predictors of coronary artery disease in patients referred for angiography.Low-grade inflammation, endothelial activation and carotid intima-media thickness in type 2 diabetes.Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up.
P2860
Q30486777-6C413B9E-8B45-40BA-8623-645C422A1CF6Q30763122-634E9ABD-6C52-4038-9BEE-42B238796E91Q33693211-80B1B246-66FE-4E40-9720-8CB72D4C2BC6Q34005103-FD4F4CBA-B4C7-47BF-AD7C-3F84509BBCEAQ34016134-11F71649-EB0F-4ED2-95B4-DCAD3E0B74CAQ34374943-F5FEE624-256C-40C5-B340-0DE91A027CDAQ34607241-C1C5F08F-162A-492F-9F81-076C8B6E775BQ34986430-85026E45-1206-4076-9CAD-D1279AD656C2Q35072544-58777BCC-1FD3-46AC-B706-43CAE084EE26Q35684185-E0FB486A-762A-4FF0-8994-930F117ED617Q36026534-3D9B8DCD-41D1-4CDC-8B62-8039134CBB54Q36251197-BD82B97A-6716-49A7-9727-39F926F52D52Q36283501-E19E3E74-193E-4FD7-A6C5-7F3B603BC9B7Q36396314-C3D4EBE4-32CC-4A05-984B-A4EF97C00464Q36403750-1BA90DCE-EBCB-4994-8CF7-9F78499E1445Q36817529-A880B226-A280-4C53-A763-EE2AAB741405Q37073309-C36BCF09-6CCE-4A01-B400-9C18D9199ECAQ37134456-45CD1B9E-6312-4822-8781-3121AAC6288AQ37202126-4BC084F2-9505-4F63-B003-6FBFB35BAF3CQ37206902-FF692751-D9FB-493A-AECF-8D86ADC31398Q37316791-37E462C9-5922-4301-B789-763323609903Q37582207-C2EE6C6D-5F6D-45A9-B08C-509D0F712692Q37639142-AADC37C4-C294-406C-8B36-7AD6F2569311Q37658732-5C85EF30-CC0F-4DF3-A5E0-3DA209A07ABFQ37704055-8C2D0603-7364-4157-B7AF-DD1A93FE1D21Q37902963-EF90F7DA-E5FA-466B-A3CA-0BD634D84414Q37995534-63524AE0-E11E-40F0-9243-8DA0E4AC8CFEQ38076079-1219F011-33D6-4110-AFD1-42CDB37A8671Q38233801-CE7CF21C-B8C0-4DC8-ABA8-4C43FEF9EDC5Q39165368-5C698B27-F487-4BA8-8F68-366DA0A2E8E7Q40090236-EBF0A4EB-3445-4DCC-A78C-2BB65337D2A2Q40449493-34FEFD69-EB7C-4108-89E3-F9AE95DC05A9Q40702333-A4A584DA-1DA2-42B2-80CE-4B732431EC8DQ41332165-C49412B2-D615-4408-A32D-3306C8BE412AQ41495295-89BF98DE-9777-487E-AC88-467DD2D62028Q42088161-44A63E74-AD7D-42C8-8210-FD94EA07F698Q43227478-042FF968-0E3F-4D8E-8880-096F52153A71Q43254439-A86290DA-1A2B-46CD-B129-6E2BFF7D6B95Q44981844-42615F59-F5F7-4910-B5F3-AB7F505ED3B8Q45200533-2262C3CC-EAE5-4AD1-933B-A26E90D0AF6D
P2860
C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
C-reactive protein and angiogr ...... risk in subjects with angina.
@en
type
label
C-reactive protein and angiogr ...... risk in subjects with angina.
@en
prefLabel
C-reactive protein and angiogr ...... risk in subjects with angina.
@en
P2093
P1476
C-reactive protein and angiogr ...... risk in subjects with angina.
@en
P2093
Benjamin D Horne
Intermountain Heart Collaboration Study Group
James S Zebrack
Jeffrey L Anderson
Joseph B Muhlestein
P304
P356
10.1016/S0735-1097(01)01804-6
P407
P577
2002-02-01T00:00:00Z